Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
Open Access
- 5 November 2018
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 18 (1), 93-106
- https://doi.org/10.1016/j.autrev.2018.08.003
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS CohortPLOS ONE, 2013
- Impact of Rheumatoid Arthritis Disease Activity Test on Clinical PracticePLOS ONE, 2013
- Mechanistic biomarkers for clinical decision making in rheumatic diseasesNature Reviews Rheumatology, 2013
- Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatmentArthritis & Rheumatism, 2011
- Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damageProceedings of the National Academy of Sciences of the United States of America, 2011
- Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo GroupArthritis & Rheumatism, 2011
- A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosusArthritis Care & Research, 2009
- A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritisRheumatology, 2009
- Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximabAnnals Of The Rheumatic Diseases, 2007
- Follicular B helper T cells in antibody responses and autoimmunityNature Reviews Immunology, 2005